Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation

University of Sao Paulo44 enrolled

Overview

The study wants to show if the medication etoricoxib 120 mg have reduces the patients pain during the laser photocoagulation, for diabetic retinopathy.

To do so we compare two group of patients, randomized 1:1, one use the medication(etoricoxib) and other use placebo and they quantify the pain using the Pain visual analogue scale

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Proliferative Diabetic Retinopathy

Interventions

placebo (Control Group)DRUG

Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation

Etoricoxib (Treatment Group)DRUG

Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation

Eligibility

Sex: ALLMin age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with diabetic retinopathy that needs laser photocoagulation for the first time Exclusion Criteria: * Younger than 17 * Signs and symptoms of liver dysfunction or abnormal liver function tests * Gastrointestinal diseases * Pregnant women * Edema * Pre-existing cardiac insufficiency

Locations (1)

Clinica Oftalmologica do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, Brazil

Outcomes

Primary Outcomes

The group taking the etoricoxib feel less pain then the group taking placebo

Time frame: After each laser session

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.